Anders Österborg

5.4k citations

78 papers · 3.4k indexed · h-index 28

Impact in

Hematology top 0.5%
- Erythropoietin and Anemia Treatment
- Multiple Myeloma Research and Treatments
- Iron Metabolism and Disorders
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Genetics 34
- Chronic Lymphocytic Leukemia Research 26
- Hemoglobinopathies and Related Disorders 8
Hematology 33
- Multiple Myeloma Research and Treatments 17
- Erythropoietin and Anemia Treatment 14

Co-authors: Håkan Mellstedt (34 shared papers)Gerassimos A. Pangalis (1 shared paper)Martin J.S. Dyer (2 shared papers)Daniel Catovsky (1 shared paper)Y Bastion (1 shared paper)Donald Bunjes (1 shared paper)Jeanette Lundin (8 shared papers)Susanne Bergenbrant (8 shared papers)
Journals: Blood (17 papers)British Journal of Haematology (6 papers)Journal of Clinical Oncology (5 papers)Leukemia (4 papers)Clinical Cancer Research (3 papers)
Partner nations: Sweden United States Iran

In The Last Decade

Anders Österborg

76 papers receiving 3.3k citations

Peers

Countries citing papers authored by Anders Österborg

Since Specialization

Citations

This map shows the geographic impact of Anders Österborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Österborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Österborg more than expected).

Fields of papers citing papers by Anders Österborg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Österborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Österborg. The network helps show where Anders Österborg may publish in the future.

Co-authors

The 25 scholars most cited alongside Anders Österborg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anders Österborg Line = papers co-authored together Anders Österborg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia. Journal of Clinical Oncology ·Anders Österborg, Martin J.S. Dyer, Donald Bunjes, Gerassimos A. Pangalis, Y Bastion, Daniel Catovsky, Håkan Mellstedt	1997	410
2	Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01 Journal of Clinical Oncology ·Francesco d’Amore, Thomas Relander, Grete F. Lauritzsen, Esa Jantunen, Hans Hagberg, Harald Anderson, Harald Holte, Anders Österborg, Mats Merup, Peter de Nully Brown, Outi Kuittinen, Martin Erlanson, Bjørn Østenstad, Unn-Merete Fagerli, Ole Gadeberg, Christer Sundström, Jan Delabie, Elisabeth Ralfkiær, Martine Vornanen, Helle Toldbod	2012	386
3	Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients Blood ·Eva Hellström-Lindberg, Tomas Ahlgren, Yves Béguin, Magnus Carlsson, Jan Carneskog, Inger Marie S. Dahl, Ingunn Dybedal, Gunnar Grimfors, Lena Kanter‐Lewensohn, Olle Linder, Michaela Luthman, Eva Löfvenberg, Herman Nilsson‐Ehle, Jan Samuelsson, Jon‐Magnus Tangen, Ingemar Winqvist, Gunnar Öberg, Anders Österborg, Åke Öst	1998	219
4	CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma. Journal of Clinical Oncology ·Jeanette Lundin, Anders Österborg, G. Brittinger, D. Crowther, Hervé Dombret, Andreas Engert, A. A. Epenetos, Christian Gisselbrecht, D. Huhn, Ulrich Jaeger, Jacob G. Thomas, Robert Marcus, Nicholas Nissen, C Poynton, Elaine M. Rankin, R. Stahel, M. Uppenkamp, Roel Willemze, Håkan Mellstedt	1998	187
5	Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines Annals of Oncology ·Matti Aapro, Yves Béguin, Carsten Bokemeyer, Mario Dicato, Pere Gascón, John A. Glaspy, Axel Hofmann, Hartmut Link, T. Littlewood, Heinz Ludwig, Anders Österborg, P. Pronzato, Valeria Santini, D. Schrijvers, R. Stauder, Kim Jordan, Jørn Herrstedt	2017	173
6	Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study Leukemia ·M Hedenus, G Birgegård, Per Näsman, Lucia Ahlberg, Torbjörn Karlsson, Birgitta Lauri, Jeanette Lundin, Gerd Lärfars, Anders Österborg	2007	159
7	Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone Blood ·Thomas Strömberg, Anna Dimberg, Anna Hammarberg, Kristina Carlson, Anders Österborg, Kenneth Nilsson, Helena Jernberg‐Wiklund	2003	133
8	Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies Blood ·Qing Yi, Anders Österborg, Susanne Bergenbrant, Håkan Mellstedt, G. Holm, Lefvert Ak	1995	97
9	Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia Leukemia ·Jeanette Lundin, Anna Porwit‐MacDonald, Eva Rossmann, Claes Karlsson, Peter Edman, Mohammad-Reza Rezvany, Eva Kimby, Anders Österborg, Håkan Mellstedt	2004	91
10	Interleukin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma British Journal of Haematology ·Chengyun Zheng, DeRen Huang, Susanne Bergenbrant, Anne Sundblad, Anders Österborg, Magnus Björkholm, Göran Holm, Qing Yi	2000	77
11	Polycomb Target Genes Are Silenced in Multiple Myeloma PLoS ONE ·Antonia Kalushkova, Mårten Fryknäs, Miguel Lemaire, Charlotte Fristedt, Prasoon Agarwal, Maria Eriksson, Sarah Deleu, Peter Atadja, Anders Österborg, Kenneth Nilsson, Karin Vanderkerken, Fredrik Öberg, Helena Jernberg‐Wiklund	2010	76
12	Randomized, dose‐finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies British Journal of Haematology ·Michael Hedenus, Søren B. Hansen, Kerry Taylor, Chris Arthur, Bertold Emmerich, Claire Dewey, David I. Watson, Gregory Rossi, Anders Österborg, (unknown)	2002	75
13	Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell–tumour hybrids in B-CLL Leukemia ·Parviz Kokhaei, Mohammad-Reza Rezvany, Lena Virving, A Choudhury, Hodjattallah Rabbani, Anders Österborg, Håkan Mellstedt	2003	65
14	Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D Leukemia ·Anna Olsson, Tania Díaz, Miguel Aguilar‐Santelises, Anders Österborg, Fredrik Celsing, Mikael Jondal, LM Osorio	2001	64
15	Signalling molecules and cytokine production in T cells of multiple myeloma‐increased abnormalities with advancing stage British Journal of Haematology ·Fariba Mozaffari, Lotta Hansson, Shahryar Kiaii, Xiuli Ju, Eva Rossmann, Hodjattallah Rabbani, Håkan Mellstedt, Anders Österborg	2004	63
16	Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target Oncotarget ·Prasoon Agarwal, Mohammad Alzrigat, Alba Atienza Párraga, Stefan Enroth, Umashankar Singh, Johanna Ungerstedt, Anders Österborg, Peter J. Brown, Anqi Ma, Jian Jin, Kenneth Nilsson, Fredrik Öberg, Antonia Kalushkova, Helena Jernberg‐Wiklund	2016	60
17	Preclinical studies of erythropoietin receptor expression in tumour cells: Impact on clinical use of erythropoietic proteins to correct cancer-related anaemia European Journal of Cancer ·Anders Österborg, Matti Aapro, Paul Cornes, Anton Haselbeck, Colin Hayward, Wolfgang Jelkmann	2006	59
18	Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis—A critical review Critical Reviews in Oncology/Hematology ·Yves Béguin, Matti Aapro, H Ludwig, Lee Mizzen, Anders Österborg	2013	58
19	Idiotype‐specific T cells in multiple myeloma stage I: an evaluation by four different functional tests British Journal of Haematology ·Anders Österborg, Qing Yi, Susanne Bergenbrant, Göran Holm, Ann‐Kari Lefvert, Hakan Mekkstedt	1995	57
20	The therapeutic use of monoclonal antibodies in colorectal carcinoma. PubMed ·Hákan Mellstedt, Frödin Je, Giuseppe Masucci, Peter Ragnhammar, Jan Fagerberg, Hjelm Al, J. Shetye, Peter Wersäll, Anders Österborg	1991	56

About Anders Österborg

Anders Österborg is a scholar working on Genetics, Hematology, Immunology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 78 papers that have together received 3.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (26 papers), Lymphoma Diagnosis and Treatment (17 papers), Multiple Myeloma Research and Treatments (17 papers), Erythropoietin and Anemia Treatment (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), T-cell and B-cell Immunology (11 papers), Immunotherapy and Immune Responses (9 papers) and Hemoglobinopathies and Related Disorders (8 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (994 citations), Immunology (1.2k citations), Pathology and Forensic Medicine (986 citations) and Oncology (1.0k citations). Anders Österborg has collaborated with scholars based in Sweden, United States and Iran. Frequent co-authors include Håkan Mellstedt, Gerassimos A. Pangalis, Martin J.S. Dyer, Daniel Catovsky, Y Bastion, Donald Bunjes, Jeanette Lundin, Susanne Bergenbrant, Hodjattallah Rabbani and Helena Jernberg‐Wiklund. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Leukemia and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact